专利号:US-12291505-B2 优先权日:2016-07-04 标题 :Methods for the synthesis of deuterated dextromethorphan 发明人:JOHNSON MATT; ZHAO CUNXIANG; MENG WEIHUA; LU ZHIJUN; LI YAN 权利人:AVANIR PHARMACEUTICALS INC 摘要:The application describes methods for making a deuterated dextromethorphan of Formula (I), deuterated dextromethorphan produced by these methods, and pharmaceutically acceptable salts thereof.
专利号:US-2024124402-A1 优先权日:2016-07-04 标 题:Methods for the synthesis of deuterated dextromethorphan
专利号:US-2024067608-A1 优先权日:2016-07-04 标 题:Methods for the synthesis of deuterated dextromethorphan
专利号:EP-3478664-B1 优先权日:2016-07-04 标题 :Methods for the synthesis of deuterated dextromethorphan
专利号:US-2019241525-A1 优先权日:2016-07-04 标题:Methods for the synthesis of deuterated dextromethorphan
专利号:US-10865187-B2 优先权日:2016-07-04 标题 :Methods for the synthesis of deuterated dextromethorphan
摘要:Journal of Pharmacology and Experimental Therapeutics., 109(189), 1953 [] 摘要:American Journal of Emergency Medicine., 13(174), 1995 [] 参考文献:10.2165/00002018-199207030-00004 摘要:Bem JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Saf. 1992 May;7(3):190–9. doi: 10.2165/00002018-199207030-00004. 参考文献:10.1007/s00228-005-0051-5 摘要:Funck-Brentano C, Boëlle P, Verstuyft C, Bornert C, Becquemont L, Poirier J. Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects. European Journal of Clinical Pharmacology. 2005 Nov 17;61(11):821–9. doi: 10.1007/s00228-005-0051-5.